Lyell Immunopharma News

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Jun 17 16:45 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Jun 17 16:24 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar

Jun 17 16:23 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL

Jun 17 16:19 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G

Jun 17 16:13 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W

Jun 17 16:11 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY

Jun 17 16:11 ET

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.

Feb 14 15:24 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lang Matthew

Feb 13 20:31 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.

Feb 13 20:26 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.

Feb 13 20:26 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Newton Charles W.

Feb 13 20:21 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn

Feb 13 20:21 ET

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)

Feb 13 17:52 ET

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)

Jan 29 17:37 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Newton Charles W.

Nov 20, 2023 20:55 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.

Nov 20, 2023 20:54 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn

Nov 20, 2023 20:53 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.

Nov 20, 2023 20:52 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Sep 8, 2023 16:30 ET